{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:48:13Z","timestamp":1782719293095,"version":"3.54.5"},"reference-count":57,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Diabetic retinopathy (DR) is a leading cause of preventable blindness among working-age adults. Systematic screening programmes in the United Kingdom, Ireland, and the Nordic countries have reduced diabetes-related visual loss, yet many European countries, including Croatia, lack organised screening. This narrative review examines European DR screening programmes, evaluates telemedicine and artificial intelligence (AI) as enabling technologies, and proposes a phased roadmap for a national programme in Croatia. Croatia has nearly 400,000 registered persons with diabetes, a national diabetes registry (CroDiab) linked to the Central Health Information System (CEZIH), and pilot screening data showing 40% DR prevalence among screened patients with type 2 diabetes. The proposed programme combines decentralised telemedicine-based imaging at primary care sites with centralised grading, a staged rollout across three phases targeting 400,000 annual screenings, and stepwise AI integration for triage. Successful European programmes share standardised digital imaging, trained grading workforces, embedded quality assurance, and registry linkage. With dedicated funding and sustained political commitment, Croatia could adopt a hybrid telemedicine\u2013AI model and, under favourable implementation conditions, reduce the burden of advanced DR over the coming decade.<\/jats:p>","DOI":"10.3390\/medicina62071251","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:49:33Z","timestamp":1782712173000},"page":"1251","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Roadmap for National Diabetic Retinopathy Screening in Croatia: Integrating European Evidence, Telemedicine, and AI"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3387-1115","authenticated-orcid":false,"given":"Toma","family":"Babi\u0107","sequence":"first","affiliation":[{"name":"Department of Diabetic Eye Complications, Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7535-3631","authenticated-orcid":false,"given":"Martina","family":"Tomi\u0107","sequence":"additional","affiliation":[{"name":"Department of Diabetic Eye Complications, Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7561-8858","authenticated-orcid":false,"given":"Nenad","family":"Vukojevi\u0107","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Zagreb University Hospital Centre, 10000 Zagreb, Croatia"},{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2005-6402","authenticated-orcid":false,"given":"Ivo","family":"Dumi\u0107-\u010cule","sequence":"additional","affiliation":[{"name":"Department of Nursing, University North, 104 Brigade 3, 42000 Varazdin, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0536-1502","authenticated-orcid":false,"given":"Sonja","family":"Jandrokovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Zagreb University Hospital Centre, 10000 Zagreb, Croatia"},{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea \u010caljku\u0161i\u0107","family":"Mance","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Clinical Hospital Centre Rijeka, 51000 Rijeka, Croatia"},{"name":"School of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"ref_1","unstructured":"International Diabetes Federation (2021). IDF Diabetes Atlas, IDF. [10th ed.]. Available online: https:\/\/diabetesatlas.org."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_3","unstructured":"GBD 2019 Blindness and Vision Impairment Collaborators, and Vision Loss Expert Group of the Global Burden of Disease Study (2021). Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study. Lancet Glob. Health, 9, e144\u2013e160."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"The Diabetic Retinopathy Study Research Group (1981). Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology, 88, 583\u2013600.","DOI":"10.1016\/S0161-6420(81)34978-1"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group (1985). Photocoagulation for diabetic macular edema: ETDRS Report Number 1. Arch. Ophthalmol., 103, 1796\u20131806.","DOI":"10.1001\/archopht.1985.01050120030015"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00592-017-0974-1","article-title":"The English National Screening Programme for diabetic retinopathy 2003\u20132016","volume":"54","author":"Scanlon","year":"2017","journal-title":"Acta Diabetol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e004015","DOI":"10.1136\/bmjopen-2013-004015","article-title":"A comparison of the causes of blindness certifications in England and Wales in working age adults (16\u201364 years), 1999\u20132000, with 2009\u20132010","volume":"4","author":"Liew","year":"2014","journal-title":"BMJ Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2213-8587(19)30411-5","article-title":"Screening for diabetic retinopathy: New perspectives and challenges","volume":"8","author":"Vujosevic","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_10","unstructured":"Hrvatski Zavod za Javno Zdravstvo (2025). Nacionalni Registar Osoba sa \u0160e\u0107ernom Bole\u0161\u0107u CroDiab. Izvje\u0161\u0107e za 2024\u2014Prvi Rezultati, Hrvatski Zavod za Javno Zdravstvo."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tomi\u0107, M., Vrabec, R., Ljubi\u0107, S., Prka\u010din, I., and Bulum, T. (2024). Patients with type 2 diabetes, higher blood pressure, and infrequent fundus examinations have a higher risk of sight-threatening retinopathy. J. Clin. Med., 13.","DOI":"10.3390\/jcm13092496"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11892-015-0577-6","article-title":"Automated retinal image analysis for diabetic retinopathy in telemedicine: Potential and challenges","volume":"15","author":"Sim","year":"2015","journal-title":"Curr. Diabetes Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2016.17216","article-title":"Development and validation of a deep learning algorithm for the detection of diabetic retinopathy in retinal fundus photographs","volume":"316","author":"Gulshan","year":"2016","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.2017.18152","article-title":"Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes","volume":"318","author":"Ting","year":"2017","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41746-018-0040-6","article-title":"Pivotal trial of an autonomous AI-based diagnostic system for the detection of diabetic retinopathy in primary care offices","volume":"1","author":"Lavin","year":"2018","journal-title":"npj Digit. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1464-5491.2009.02870.x","article-title":"Diabetic retinopathy screening: A systematic review of the economic evidence","volume":"27","author":"Jones","year":"2010","journal-title":"Diabet. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00017","article-title":"Cost-effectiveness of detecting and treating diabetic retinopathy","volume":"124","author":"Javitt","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S2589-7500(20)30060-1","article-title":"Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: An economic analysis modelling study","volume":"2","author":"Xie","year":"2020","journal-title":"Lancet Digit. Health"},{"key":"ref_20","unstructured":"Public Health England (2021). NHS Screening Programmes in England: 2019 to 2020, PHE."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19740","article-title":"Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening","volume":"19","author":"Scanlon","year":"2015","journal-title":"Health Technol. Assess."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.healthpol.2019.05.001","article-title":"Worlds of Healthcare: A Healthcare System Typology of OECD Countries","volume":"123","author":"Reibling","year":"2019","journal-title":"Health Policy"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.healthpol.2018.08.003","article-title":"A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries","volume":"122","author":"Turnbull","year":"2018","journal-title":"Health Policy"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2016.08.016","article-title":"Trends in blindness due to diabetic retinopathy among adults aged 18\u201369 years over a decade in Ireland","volume":"121","author":"Tracey","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40942-024-00534-8","article-title":"Present and future screening programs for diabetic retinopathy: A narrative review","volume":"10","author":"Dinesen","year":"2024","journal-title":"Int. J. Retin. Vitr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/aos.12278","article-title":"Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment","volume":"92","author":"Hautala","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000368426","article-title":"Screening for diabetic retinopathy in the central region of Portugal. Added value of automated \u2018disease\/no disease\u2019 grading","volume":"233","author":"Ribeiro","year":"2015","journal-title":"Ophthalmologica"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Matuszewski, W., Baranowska-Jurkun, A., Stefanowicz-Rutkowska, M.M., Modzelewski, R., Pieczynski, J., and Bandurska-Stankiewicz, E. (2020). Prevalence of diabetic retinopathy in type 1 and type 2 diabetes mellitus patients in north-east Poland. Medicina, 56.","DOI":"10.3390\/medicina56040164"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6646645","DOI":"10.1155\/2021\/6646645","article-title":"Diabetic retinopathy screening in patients with diabetes using a handheld fundus camera: The experience from the south-eastern region in Hungary","volume":"2021","author":"Eszes","year":"2021","journal-title":"J. Diabetes Res."},{"key":"ref_30","first-page":"1","article-title":"The burden of macular diseases in Central and Eastern Europe\u2014Implications for healthcare systems","volume":"19","author":"Balciuniene","year":"2019","journal-title":"Value Health Reg. Issues"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00592-021-01687-w","article-title":"The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges","volume":"58","author":"Scanlon","year":"2021","journal-title":"Acta Diabetol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.pcd.2023.06.004","article-title":"Geographic variation in diabetic retinopathy screening within the Veterans Health Administration","volume":"17","author":"Davis","year":"2023","journal-title":"Prim. Care Diabetes"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1089\/tmj.2021.0118","article-title":"Implementation of teleretinal screening using optical coherence tomography in the Veterans Health Administration","volume":"27","author":"Ashrafzadeh","year":"2021","journal-title":"Telemed. e-Health"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","article-title":"Guidelines on diabetic eye care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings","volume":"125","author":"Wong","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kanclerz, P., Tuuminen, R., and Khoramnia, R. (2021). Imaging modalities employed in diabetic retinopathy screening: A review and meta-analysis. Diagnostics, 11.","DOI":"10.3390\/diagnostics11101802"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/OPTH.S442414","article-title":"Addressing technical failures in a diabetic retinopathy screening program","volume":"18","author":"Brennan","year":"2024","journal-title":"Clin. Ophthalmol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41433-020-0961-6","article-title":"Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group","volume":"34","author":"Amoaku","year":"2020","journal-title":"Eye"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41433-018-0064-9","article-title":"Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence","volume":"32","author":"Rajalakshmi","year":"2018","journal-title":"Eye"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ophtha.2013.05.004","article-title":"Peripheral lesions identified by mydriatic ultrawide field imaging: Distribution and potential impact on diabetic retinopathy severity","volume":"120","author":"Silva","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_40","unstructured":"NHS England (2026, May 23). Diabetic Eye Screening Programme: KPI Data, 2022\u20132023, Available online: https:\/\/www.gov.uk\/government\/publications\/diabetic-eye-screening-2022-to-2023-data."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/dia.2019.0164","article-title":"The value of automated diabetic retinopathy screening with the EyeArt system: A study of more than 100,000 consecutive encounters from people with diabetes","volume":"21","author":"Bhaskaranand","year":"2019","journal-title":"Diabetes Technol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"105320","DOI":"10.1016\/j.cmpb.2020.105320","article-title":"Deep learning algorithms for detection of diabetic retinopathy in retinal fundus photographs: A systematic review and meta-analysis","volume":"191","author":"Islam","year":"2020","journal-title":"Comput. Methods Programs Biomed."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Beede, E., Baylor, E., Hersch, F., Iurchenko, A., Wilcox, L., Ruamviboonsuk, P., and Vardoulakis, L.M. (2020, January 25\u201330). A human-centered evaluation of a deep learning system deployed in clinics for the detection of diabetic retinopathy. Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems, Honolulu, HI, USA.","DOI":"10.1145\/3313831.3376718"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41746-019-0099-8","article-title":"Deep learning versus human graders for classifying diabetic retinopathy severity in a nationwide screening program","volume":"2","author":"Ruamviboonsuk","year":"2019","journal-title":"npj Digit. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ophtha.2016.11.014","article-title":"Automated diabetic retinopathy image assessment software: Diagnostic accuracy and cost-effectiveness compared with human graders","volume":"124","author":"Tufail","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bjophthalmol-2020-316594","article-title":"Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30,000 patients","volume":"105","author":"Heydon","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_47","unstructured":"European Commission (2026, May 23). Regulation (EU) 2017\/745 of the European Parliament and of the Council on Medical Devices. Available online: https:\/\/eur-lex.europa.eu\/eli\/reg\/2017\/745\/oj\/eng."},{"key":"ref_48","unstructured":"European Commission (2026, May 23). Regulation (EU) 2024\/1689 of the European Parliament and of the Council of 13 June 2024 Laying down Harmonised Rules on Artificial Intelligence (Artificial Intelligence Act). Available online: https:\/\/eur-lex.europa.eu\/eli\/reg\/2024\/1689\/oj\/eng."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s11263-019-01228-7","article-title":"Grad-CAM: Visual explanations from deep networks via gradient-based localization","volume":"128","author":"Selvaraju","year":"2020","journal-title":"Int. J. Comput. Vis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41467-023-44676-z","article-title":"Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: The ACCESS randomized control trial","volume":"15","author":"Wolf","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_51","unstructured":"Drummond, M.F., Sculpher, M.J., Claxton, K., Stoddart, G.L., and Torrance, G.W. (2015). Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press. [4th ed.]."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e046264","DOI":"10.1136\/bmjopen-2020-046264","article-title":"Effect of ethnicity and other sociodemographic factors on attendance at diabetic eye screening: A 12-month retrospective cohort study","volume":"11","author":"Seltene","year":"2021","journal-title":"BMJ Open"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jamaophthalmol.2023.5287","article-title":"Social determinants of health and perceived barriers to care in diabetic retinopathy screening","volume":"141","author":"Ravindranath","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22290","article-title":"What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis","volume":"22","author":"Lawrenson","year":"2018","journal-title":"Health Technol. Assess."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00410281","article-title":"Methodology for retinal photography and assessment of diabetic retinopathy: The EURODIAB IDDM Complications Study","volume":"38","author":"Aldington","year":"1995","journal-title":"Diabetologia"},{"key":"ref_56","unstructured":"European Commission (2026, May 23). Regulation (EU) 2016\/679 of the European Parliament and of the Council of 27 April 2016 on the Protection of Natural Persons with Regard to the Processing of Personal Data (General Data Protection Regulation). Available online: https:\/\/eur-lex.europa.eu\/eli\/reg\/2016\/679\/oj\/eng."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000502387","article-title":"Strategies to tackle the global burden of diabetic retinopathy: From epidemiology to artificial intelligence","volume":"243","author":"Wong","year":"2020","journal-title":"Ophthalmologica"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1251\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:28:11Z","timestamp":1782718091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071251"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071251","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}